Assertio Holdings (ASRT) - התחייבויות לטווח ארוך להון

Geopolitical tensions are limiting the export of neurological drugs and access to foreign substances. The ratio of long-term debt to equity allows for a risk assessment, where 0.52 serves as the base parameter value. Demand for analgesics remains stable, ensuring the business's resilience to economic cycles. Meanwhile, Assertio Holdings, Inc. (ASRT) logistics hubs and packaging capacities are operating without downtime.

Earnings volatility at Assertio Holdings, Inc. (ASRT) driven by neurology patent risks necessitates strict control over the liability structure. This ratio correlates liabilities with maturities exceeding one year against equity. This allows for an assessment of the business's dependence on external borrowing amidst unstable cash flows. Reducing leverage ensures the company's survival during periods of declining demand. The trend of the long-term financial stability indicator regarding debt determines the issuer's margin of safety.